654 related articles for article (PubMed ID: 24528208)
21. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
[TBL] [Abstract][Full Text] [Related]
22. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
[TBL] [Abstract][Full Text] [Related]
23. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
24. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
[TBL] [Abstract][Full Text] [Related]
25. Effects of Mpl ligands on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Kelly AB
Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
[TBL] [Abstract][Full Text] [Related]
26. [Clinical use of thrombopoietin (c-Mpl Ligand)].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
[TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin: understanding and manipulating platelet production.
Kaushansky K
Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
[TBL] [Abstract][Full Text] [Related]
28. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
29. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
Elife; 2021 Jun; 10():. PubMed ID: 34059198
[TBL] [Abstract][Full Text] [Related]
30. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
31. Determinants of platelet number and regulation of thrombopoiesis.
Kaushansky K
Hematology Am Soc Hematol Educ Program; 2009; ():147-52. PubMed ID: 20008193
[TBL] [Abstract][Full Text] [Related]
32. An overview of thrombopoietin: with a historical perspective.
Levin J
C R Acad Sci III; 1995 May; 318(5):609-18. PubMed ID: 7671007
[TBL] [Abstract][Full Text] [Related]
33. Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.
Abraham M; Weiss ID; Wald H; Wald O; Nagler A; Beider K; Eizenberg O; Peled A
Br J Haematol; 2013 Oct; 163(2):248-59. PubMed ID: 23906028
[TBL] [Abstract][Full Text] [Related]
34. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
[TBL] [Abstract][Full Text] [Related]
35. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
36. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
37. Activation of toll-like receptors 2 and 4 on CD34
D'Atri LP; Rodríguez CS; Miguel CP; Pozner RG; Ortiz Wilczyñski JM; Negrotto S; Carrera-Silva EA; Heller PG; Schattner M
J Thromb Haemost; 2019 Dec; 17(12):2196-2210. PubMed ID: 31397069
[TBL] [Abstract][Full Text] [Related]
38. IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs.
Nishimura S; Nagasaki M; Kunishima S; Sawaguchi A; Sakata A; Sakaguchi H; Ohmori T; Manabe I; Italiano JE; Ryu T; Takayama N; Komuro I; Kadowaki T; Eto K; Nagai R
J Cell Biol; 2015 May; 209(3):453-66. PubMed ID: 25963822
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietic agents.
Stasi R; Bosworth J; Rhodes E; Shannon MS; Willis F; Gordon-Smith EC
Blood Rev; 2010; 24(4-5):179-90. PubMed ID: 20493600
[TBL] [Abstract][Full Text] [Related]
40. The role of platelet factor 4 in radiation-induced thrombocytopenia.
Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
